+

WO2003086267B1 - Systeme capsulaire a plusieurs compartiments et plusieurs phases - Google Patents

Systeme capsulaire a plusieurs compartiments et plusieurs phases

Info

Publication number
WO2003086267B1
WO2003086267B1 PCT/US2003/010816 US0310816W WO03086267B1 WO 2003086267 B1 WO2003086267 B1 WO 2003086267B1 US 0310816 W US0310816 W US 0310816W WO 03086267 B1 WO03086267 B1 WO 03086267B1
Authority
WO
WIPO (PCT)
Prior art keywords
capsule
receiving chamber
compartment
chamber
primary
Prior art date
Application number
PCT/US2003/010816
Other languages
English (en)
Other versions
WO2003086267A2 (fr
WO2003086267A3 (fr
Inventor
Fred H Miller
Lance R Ausec
Original Assignee
Fred H Miller
Lance R Ausec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/369,244 external-priority patent/US20030194429A1/en
Priority to AU2003220689A priority Critical patent/AU2003220689A1/en
Priority to CA2481486A priority patent/CA2481486C/fr
Priority to JP2003583294A priority patent/JP2005528383A/ja
Priority to NZ536267A priority patent/NZ536267A/en
Priority to EP03717010A priority patent/EP1499303A4/fr
Application filed by Fred H Miller, Lance R Ausec filed Critical Fred H Miller
Publication of WO2003086267A2 publication Critical patent/WO2003086267A2/fr
Publication of WO2003086267A3 publication Critical patent/WO2003086267A3/fr
Priority to US10/804,576 priority patent/US7670612B2/en
Publication of WO2003086267B1 publication Critical patent/WO2003086267B1/fr
Priority to US12/689,669 priority patent/US8361497B2/en
Priority to US13/746,743 priority patent/US20130136791A1/en
Priority to US14/036,521 priority patent/US9241911B2/en
Priority to US15/005,508 priority patent/US9539216B2/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C39/00—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor
    • B29C39/02—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor for making articles of definite length, i.e. discrete articles
    • B29C39/10—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor for making articles of definite length, i.e. discrete articles incorporating preformed parts or layers, e.g. casting around inserts or for coating articles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/0058—Liquid or visquous
    • B29K2105/0061—Gel or sol

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne une capsule à plusieurs compartiments comprenant une première chambre réceptrice renfermant au moins un ingrédient présentant un premier état physique, lequel ingrédient est sélectionné dans un groupe renfermant un nutraceutique, une vitamine, un complément alimentaire et un minéral ; ainsi qu'une seconde chambre réceptrice renfermant au moins un ingrédient présentant un second état physique, lequel ingrédient est sélectionné dans le groupe renfermant un nutraceutique, une vitamine, un complément alimentaire et un minéral. Selon cette invention, le premier état physique de l'ingrédient contenu dans la première chambre réceptrice est différent du second état physique de l'ingrédient contenu dans la seconde chambre réceptrice, lequel ingrédient contenu dans la première chambre réceptrice est différent de celui contenu dans la seconde chambre réceptrice.
PCT/US2003/010816 2002-04-10 2003-04-09 Systeme capsulaire a plusieurs compartiments et plusieurs phases WO2003086267A2 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AU2003220689A AU2003220689A1 (en) 2002-04-10 2003-04-09 Multi-phase, multi-compartment capsular system
CA2481486A CA2481486C (fr) 2002-04-10 2003-04-09 Systeme capsulaire a plusieurs compartiments et plusieurs phases
JP2003583294A JP2005528383A (ja) 2002-04-10 2003-04-09 多重相・複数コンパートメントカプセルシステム
NZ536267A NZ536267A (en) 2002-04-10 2003-04-09 Multi-phase, multi-compartment and multi-ingredient capsular system
EP03717010A EP1499303A4 (fr) 2002-04-10 2003-04-09 Systeme capsulaire a plusieurs compartiments et plusieurs phases
US10/804,576 US7670612B2 (en) 2002-04-10 2004-03-19 Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
US12/689,669 US8361497B2 (en) 2002-04-10 2010-01-19 Multi-phase, multi-compartment, capsular delivery apparatus and methods for using the same
US13/746,743 US20130136791A1 (en) 2002-04-10 2013-01-22 Multi-phase, mult-compartment capsular delivery apparatus and methods for using same
US14/036,521 US9241911B2 (en) 2002-04-10 2013-09-25 Multi-phase, multi-compartment, capsular delivery apparatus and methods for using same
US15/005,508 US9539216B2 (en) 2002-04-10 2016-01-25 Multi-phase, multi-compartment, capsular delivery apparatus and methods for using same

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US37144802P 2002-04-10 2002-04-10
US60/371,448 2002-04-10
US10/369,244 US20030194429A1 (en) 2002-04-10 2003-02-18 Multi-phase, multi-compartment capsular delivery apparatus for therapeutic compositions and methods for using same
US10/369,427 US20030194431A1 (en) 2002-04-10 2003-02-18 Multi-phase,multi-compartment capsular delivery apparatus and methods for using same
US10/369,247 2003-02-18
US10/369,244 2003-02-18
US10/369,247 US20030194430A1 (en) 2002-04-10 2003-02-18 Process for encapsulating multi-phase, multi-compartment capsules for therapeutic compositions
US10/368,951 2003-02-18
US10/369,427 2003-02-18
US10/368,951 US20030194428A1 (en) 2002-04-10 2003-02-18 Process for encapsulating multi-phase, multi-compartment capsules

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US37144802P Substitution 2002-04-10 2002-04-10

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/804,576 Continuation-In-Part US7670612B2 (en) 2002-04-10 2004-03-19 Multi-phase, multi-compartment capsular delivery apparatus and methods for using same

Publications (3)

Publication Number Publication Date
WO2003086267A2 WO2003086267A2 (fr) 2003-10-23
WO2003086267A3 WO2003086267A3 (fr) 2003-12-18
WO2003086267B1 true WO2003086267B1 (fr) 2004-04-29

Family

ID=29255682

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/010816 WO2003086267A2 (fr) 2002-04-10 2003-04-09 Systeme capsulaire a plusieurs compartiments et plusieurs phases

Country Status (6)

Country Link
EP (1) EP1499303A4 (fr)
JP (2) JP2005528383A (fr)
AU (3) AU2003220689A1 (fr)
CA (1) CA2481486C (fr)
NZ (1) NZ536267A (fr)
WO (1) WO2003086267A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8383579B2 (en) 2004-11-19 2013-02-26 GlaxoSmithKline, LLC Method for customized dispensing of variable dose drug combination products for individualizing of therapies

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0201936A3 (en) 1999-07-30 2004-05-28 Smithkline Beecham Plc Multi-component pharmaceutical dosage form
US20040087527A1 (en) * 2002-10-31 2004-05-06 Day Brian J. Methods for treatment of thiol-containing compound deficient conditions
US7790762B2 (en) 2002-10-31 2010-09-07 National Jewish Health Compounds and methods for thiol-containing compound efflux and cancer treatment
DE10359792A1 (de) * 2003-12-19 2005-07-21 Bayer Technology Services Gmbh Mehrphasige Wirkstoffformulierung
CN1956733B (zh) * 2004-04-07 2012-10-10 白藜芦醇合伙人有限责任公司 营养补充剂及其加工方法
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US7981908B2 (en) * 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
JP2006321730A (ja) * 2005-05-17 2006-11-30 Maruzen Pharmaceut Co Ltd 抗酸化剤及び抗老化剤、並びに皮膚化粧料及び飲食物
US7781572B2 (en) 2005-10-05 2010-08-24 Nse Products, Inc. Nanosized carotenoid cyclodextrin complexes
HUE056937T2 (hu) 2006-02-03 2022-04-28 Opko Renal Llc A D-vitamin elégtelenség és hiány kezelése 25-hidroxivitamin D2-vel és 25-hidroxivitamin D3-mal
WO2008008608A2 (fr) 2006-06-21 2008-01-17 Proventiv Therapeutics, Llc Procédé de traitement et de prévention de l'hyperparathyroïdisme secondaire
DK2046334T3 (da) 2006-07-25 2014-08-25 Vecta Ltd Sammensætninger og fremgangsmåder til at hæmme mavesyresekretion ved at anvende derivater af små dicarboxylsyrer i kombination med PPI
US20130115320A1 (en) 2007-03-30 2013-05-09 Dynova Laboratories, Inc. Therapeutic agent for intranasal administration and method of making and using same
PL2148684T3 (pl) 2007-04-25 2013-06-28 Cytochroma Inc Sposób leczenia niedoboru i deficytu witaminy D
CA2683997C (fr) 2007-04-25 2016-11-08 Cytochroma Inc. Compositions orales a liberation controlee comprenant des composes de vitamine d et un vehicule cireux
CA2639895C (fr) 2007-10-05 2014-06-10 David Rowland Compositions energisantes comportant du trefle rouge goji et de la renouee a fleurs multiples et leurs utilisations
US20120145572A1 (en) * 2009-04-20 2012-06-14 Ecole Polytechnique Federale De Lausanne (Epfl) Containers assembled in fluid and corresponding production
KR101143997B1 (ko) * 2010-03-04 2012-05-09 한미사이언스 주식회사 유산균 제제 및 5-ｈｔ4 수용체 효능제를 함유하는 경구 투여용 복합 제제 및 이의 제조방법
HUE048464T2 (hu) 2010-03-29 2020-07-28 Opko Ireland Global Holdings Ltd Módszerek és készítmények mellékpajzsmirigy szintjének csökkentésére
CA3065589C (fr) 2010-06-03 2022-04-26 Catalent Ontario Limited Capsules multiphases de gel mou, appareil et procede pour celles-ci
KR101849146B1 (ko) * 2010-07-19 2018-04-16 프로갑스 에스.에이. 캡슐 내부에 캡슐 또는 다른 고형 제형을 캡슐화하는 것을 위한 장치 및 방법
US20120082719A1 (en) * 2010-10-05 2012-04-05 Sam Poon Ang Compositions For Treating Chronic Viral Infections
CN102335095A (zh) * 2011-10-12 2012-02-01 李思思 d-柠檬烯硬胶囊的一种制造技术
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
WO2014146077A1 (fr) 2013-03-15 2014-09-18 Incube Labs, Llc Plateforme d'administration de médicament biodégradable multistade
US10220047B2 (en) * 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US9980993B2 (en) 2014-11-06 2018-05-29 NWO Stem Cure, LLC Nutraceutical supplement with Lactobacillus rhamnosus
US9468659B2 (en) 2014-11-06 2016-10-18 NWO Stem Cure, LLC Nutraceutical supplement with Lactobacillus rhamnosus
US11173168B2 (en) 2016-03-28 2021-11-16 Eirgen Pharma Ltd. Methods of treating vitamin D insufficiency in chronic kidney disease
CN108753621A (zh) * 2018-05-30 2018-11-06 昆明理工大学 一种基于糖蜜废醪液提高单针藻油脂积累的方法
JP7229012B2 (ja) * 2018-12-25 2023-02-27 小林製薬株式会社 内服用医薬組成物
IT201900025063A1 (it) * 2019-12-20 2021-06-20 Idi Integratori Dietetici Italiani S R L Composizioni gastroresistenti comprendi inositolo e/o estratto di gymnema sylvestre, loro composizioni farmaceutiche e nutraceutiche e loro uso
WO2023023999A1 (fr) * 2021-08-26 2023-03-02 宁德时代新能源科技股份有限公司 Sac de liquide, élément de batterie, batterie et dispositif d'alimentation
CN118948861B (zh) * 2024-10-15 2024-12-24 山东和美欣动物药业有限公司 一种鸡源胆汁提取物牛磺鹅去氧胆酸组合物及其在制备提升芦丁鸡产蛋期抗应激药物中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2729068A1 (de) * 1977-06-28 1979-01-11 Rainer Dr Med Liedtke Verfahren zur freisetzungssteuerung von arzneimitteln aus kapseln
US4185740A (en) * 1978-08-02 1980-01-29 Johnson & Johnson Disposable capsules
CH661878A5 (de) * 1983-11-04 1987-08-31 Warner Lambert Co Kapsel-dosierungsformen.
JPS6342094Y2 (fr) * 1985-07-02 1988-11-04
DE3543154A1 (de) * 1985-12-06 1987-06-11 Boehringer Ingelheim Kg Teilbare kapsel
US4940499A (en) * 1989-05-23 1990-07-10 Warner-Lambert Company Method and apparatus for sealing capsules containing medicaments
DK0487575T3 (da) * 1989-08-17 1994-11-28 Cortecs Ltd Farmaceutiske formuleringer
US5501857A (en) * 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
JPH06316517A (ja) * 1993-02-22 1994-11-15 Grelan Pharmaceut Co Ltd 放出制御製剤
JP2000239159A (ja) * 1999-02-19 2000-09-05 Nitto Yakuhin Kogyo Kk カプセル剤およびその製造方法
ITMI20000788A1 (it) * 1999-04-13 2001-10-11 Beecham Pharmaceuticals Pte Li Nuovo metodo di trattamento
GB2358382B (en) * 1999-11-17 2003-01-29 Reckitt Benckiser Rigid water-soluble containers
US6372252B1 (en) * 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
DE60126089T2 (de) * 2000-07-20 2007-11-08 MW Encap Ltd., Livingston Verabreichungssystem

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8383579B2 (en) 2004-11-19 2013-02-26 GlaxoSmithKline, LLC Method for customized dispensing of variable dose drug combination products for individualizing of therapies

Also Published As

Publication number Publication date
CA2481486A1 (fr) 2003-10-23
NZ536267A (en) 2007-06-29
AU2003220689A1 (en) 2003-10-27
JP2011068664A (ja) 2011-04-07
WO2003086267A2 (fr) 2003-10-23
EP1499303A4 (fr) 2007-07-25
AU2009202495A1 (en) 2009-07-16
JP2005528383A (ja) 2005-09-22
EP1499303A2 (fr) 2005-01-26
CA2481486C (fr) 2012-06-12
WO2003086267A3 (fr) 2003-12-18
AU2009202495B2 (en) 2011-02-10
AU2011202164A1 (en) 2011-06-02

Similar Documents

Publication Publication Date Title
WO2003086267B1 (fr) Systeme capsulaire a plusieurs compartiments et plusieurs phases
CA2397447A1 (fr) Forme reduite de coenzyme q dans des formes posologiques stables a haute biodisponibilite et applications correspondantes
CA2159580A1 (fr) Compositions pharmaceutiques renfermant la polyvinylpyrrolidone et un tri-ester; methode de preparation
CA2327723A1 (fr) Derives bicycliques de l'acide hydroxamique
IL147220A0 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
CA2214399A1 (fr) Capsule souple en gelatine avec une enveloppe comportant un derive de xanthine
NO20020055L (no) Blanding egnet for a danne en myk kapsel, samt spiselig myk kapsel.
EP0695171A1 (fr) Lyospheres contenant de la gonadotrophine
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
CA2154424A1 (fr) 1-phenyl-3-dimethylaminopropane possedant des proprietes pharmaceutiques
IL148288A0 (en) Indolealkanol ester and indolealkylamide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
CA2175529A1 (fr) Agent stabilisant synergique
WO2003014079A8 (fr) Polymorphe stable de flibanserine, procede de preparation associe et utilisation dudit polymorphe dans la preparation de medicaments
IL117091A0 (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
GEP20063972B (en) Streptogramin derivatives, preparation and compositions containing them
EE05491B1 (et) Leeliselist sfingomelinaasi sisaldav kompositsioon kasutamiseks dieteetilise valmistise, toidulisandi v?i farmatseutilise tootena
AU2841199A (en) Novel bis-benzamide derivatives, method for making same pharmaceutical compositions containing them and use thereof as medicine
WO2000076528A3 (fr) Preparation pharmaceutique
AU2001256570A1 (en) Novel anticancer compounds: process for their preparation and pharmaceutical compositions containing them
MX9603606A (es) N-metil-n-[(1s)-1-fenil-2-((3s)-3-hidroxipirrolidin-1-il) etil]-2,2-difenil-acetamida.
WO2002008222A3 (fr) Derives de heteroaryle-beta-alanine en tant qu'inhibiteurs d'alpha-4-integrine
HUP0303195A3 (en) O-substituted 6-methyl-tramadol derivatives, process for their preparation and pharmaceutical compositions containing them
ZA200100565B (en) Benzenesulfonamide compounds, a process for their preparation and pharmaceutical compositions containing them.
GEP20032924B (en) Novel Furan Diarylmethylidene Derivatives, Method for Their Preparation and Pharmaceutical Composition
HUP9800395A3 (en) Sulfonamide-substituted benzoxepine derivatives, their use as medicines and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 10804576

Country of ref document: US

B Later publication of amended claims

Effective date: 20031217

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2481486

Country of ref document: CA

Ref document number: 2003583294

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2003220689

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 536267

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2003717010

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003717010

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载